ReviewEndocrine, metabolic & immune disorders drug targets2026
Iodine Nutrition in Emilia-Romagna Region, Italy: A Successful Story of Prevention of Iodine Deficiency Disorders.
Review in Endocrine, metabolic & immune disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Emilia-Romagna region, Italy, achieved iodine sufficiency many years before the approval of Law 55/2005, which introduced a nationwide salt iodization program voluntarily in the country. Indeed, more than 10 years before the law, the Emilia-Romagna region implemented a local program of iodine, carrying out information campaigns to promote the use of iodized salt in the population. Epidemiological studies conducted between 1998 and 2005 in this region showed a progressive increase in the use of iodized salt (IS) and a median urinary iodine concentration >100 μg/L in almost all the investigated towns and villages. In 2005, when the national Law 55/2005 was approved, the prevalence of IS consumers in the Emilia-Romagna region was 60%, while it was only 30% in the rest of the country. Further studies conducted between 2011 and 2019 confirmed an adequate iodine intake in the population and the disappearance of goitre in schoolchildren, demonstrating the sustainability of the regional iodine prophylaxis program. Of note, the success obtained in this region is the result of a close collaboration between local politicians, health services, school authorities, families, and salt producers that, in the absence of dedicated funds, moved voluntarily to spread knowledge on the importance of using IS. Multiple and reiterated "on-field" initiatives experienced at the local level yielded awareness in the population on the importance of IS, suggesting that tight cooperation among stakeholders is successful in promoting large-scale programs of prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.